10/22/2015 | BKCVDDEMIGPV | Market Commentary: Hospital names fall on Community Health earnings warning; funds see $3.34 billion inflow
|
8/26/2014 | BKCVHY | S&P: LifePoint outlook to stable
|
5/1/2014 | BKCVHY | Fitch rates LifePoint notes BB
|
5/1/2014 | BKCVHY | Moody's downgrades LifePoint
|
4/30/2014 | CV | Market Commentary: Auxilium lower outright, expands on hedge after outlook cut; primary should 'tread water'
|
4/25/2014 | CV | Market Commentary: New Citrix adds as shares slip; Tesla down with shares; LifePoint active ahead of maturity
|
4/2/2014 | CV | Market Commentary: Midday Commentary: New McDermott mandatories trade better; short-dated LifePoint adds with shares
|
4/2/2014 | CV | Market Commentary: New McDermott adds; DFC Global sister convertibles surge on buyout news; 51job deal on tap
|
1/8/2014 | CV | Market Commentary: Midday Commentary: Micron pushes above par after earnings report; ADM active ahead of maturity
|
1/8/2014 | CV | Market Commentary: Micron gains outright, flat to weaker on hedge after strong earnings; Qihoo 360 improves
|
11/25/2013 | BKCVHY | Moody's ups LifePoint to SGL-2
|
11/22/2013 | BKCVHY | S&P rates LifePoint notes BB-
|
11/21/2013 | BKCVHY | Moody's rates LifePoint notes Ba1
|
11/21/2013 | BKCVHY | Fitch rates LifePoint notes BB
|
10/25/2013 | BKCVHYLM | LifePoint Hospitals ends Q3 with $1.15 billion of debt, eyes capital markets in fourth quarter
|
9/24/2013 | CV | Market Commentary: Midday Commentary: New issues still absent; homebuilders in focus; LifePoint regains footing
|
9/24/2013 | CV | Market Commentary: Lennar, KB Home flat to lower on hedge; LifePoint in line after weakness; Maiden on tap
|
7/29/2013 | BKCVHY | Moody's cuts LifePoint to SGL-3
|
4/29/2013 | CV | Market Commentary: Auxilium 'comes in' on disappointing quarter; Cemex slips on earnings; Theravance in focus
|
2/15/2013 | BKCVLM | LifePoint uses incremental term loans to fund put of 3.25% convertibles
|
2/4/2013 | BKCVHY | Moody's ups LifePoint to SGL-1
|
1/31/2013 | BKCVHY | Fitch rates LifePoint loan BB+
|
1/31/2013 | BKCVHY | S&P rates LifePoint loan BB-
|
1/31/2013 | BKCVHY | Moody's: LifePoint loan Ba1
|
9/25/2012 | BKCVHY | Moody's upgrades LifePoint
|
7/26/2012 | BKCVHY | Moody's: LifePoint loans Ba1
|
7/26/2012 | BKCVHY | Fitch: LifePoint loans BB+
|
7/25/2012 | BKCVHY | S&P rates LifePoint loan BB-
|
6/28/2012 | CV | Market Commentary: LifePoint up on health care law ruling; Navistar down; Gevo stock tanks ahead of pricing
|
6/25/2012 | BKCVHY | Fitch affirms LifePoint
|
9/26/2011 | BKCVHY | Moody's: LifePoint positive
|
7/1/2011 | BKCVHY | Fitch ups LifePoint
|
4/7/2011 | CV | Market Commentary: New Fifth Street trades around par; Newmont Mining active, slightly better dollar neutral
|
3/2/2011 | BKCVHY | LifePoint Hospitals prepared to take advantage of M&A pipeline
|
12/10/2010 | CV | Market Commentary: New HeartWare surges; ShengdaTech quiet on debut; Beckman Coulter comes in on sale talk
|
9/21/2010 | BKCVHY | S&P rates LifePoint Hospitals notes BB-
|
9/20/2010 | BKCVHY | Moody's rates LifePoint notes and loans Ba1
|
3/22/2010 | CV | Market Commentary: Amerigroup, Lifepoint better after health care bill OK'd; Kaiser Aluminum offering on tap
|
3/19/2010 | CV | Market Commentary: Hartford eases with stock; Lifepoint, other health care names steady to stronger; Rovi slips
|
2/19/2010 | CV | Market Commentary: Convertibles higher outright, but quiet; Amgen steady; Trico Marine down; LifePoint weaker
|
1/20/2010 | CV | Market Commentary: U.S. Steel lower; Medtronic mixed; some health care names lower; Lexington Realty to price
|
11/6/2009 | CV | Market Commentary: Ford convertibles weaker than issue price; Alliant Techsystems off; LifePoint paper improves
|
8/20/2009 | CV | Market Commentary: Johnson Controls rises on exchange offer; Alcoa, others bid up on speculation of exchanges
|
8/6/2009 | CV | Market Commentary: Onyx stays afloat in gray; Rayonier quiet; Alexandria, Virgin Media gain with earnings
|
7/17/2009 | CV | Market Commentary: LifePoint advances; tech names, AMD, Micron strong on Intel earnings; CIT converts diverge
|
6/9/2009 | CV | Market Commentary: Equinix adds on debut; Callaway gets par bid in gray, CMS quiet; financials extend gains
|
5/12/2009 | BKCVHY | Fitch affirms LifePoint
|
2/20/2009 | CV | Market Commentary: Financials end mixed after bouncing off lows; Eastman Kodak gets beaten up; LifePoint trades at 79
|
1/5/2009 | CV | Market Commentary: Convertibles extend gains: Qwest, Kodak, Tyson gain; LifePoint active; Ford, GM rise on sales data
|
10/23/2008 | CV | Market Commentary: Level 3, ProLogis lower after earnings; NII weaker; LifePoint Hospitals down ahead of earnings
|
9/3/2008 | BKCVHY | Moody's ups LifePoint loans to Ba1, notes to B1
|
8/11/2008 | CV | Market Commentary: UAL, airlines higher with lower oil prices; Lifepoint contracts; RadioShack, China Medical to price
|
4/28/2008 | BKCVHY | Fitch affirms LifePoint
|
1/4/2008 | CV | Market Commentary: Sallie slammed, drags down financials; Intel panned; drags down chips; OSI opens strong
|
10/16/2007 | CV | Market Commentary: Medtronic recovers some; Intel down but not out; GM details batter Ford; LifePoint, Kodak down
|
9/27/2007 | CV | Market Commentary: General Cable well-received; GM, Ford slip; AMR flies high on Icelandic air; St. Jude, LifePoint up
|
7/16/2007 | CV | Market Commentary: Intel, Newmont up; CVRD down; Health Care, KKR Financial deals coming; trading quiet on earnings
|
5/30/2007 | CV | LifePoint $75 greenshoe exercised on 3.5% convertibles, bringing total to $575 million
|
5/25/2007 | CV | Market Commentary: GM roars ahead; Archstone-Smith gains, Bausch & Lomb up, Advanced Medical quiet on takeover talk
|
5/24/2007 | CV | Market Commentary: Bausch & Lomb quiet on bidding event, Advanced Medical Optics slides; GM slightly higher in gray
|
5/23/2007 | CV | New Issue: LifePoint prices $500 million seven-year convertibles to yield 3.5%, up 36.5%
|
5/23/2007 | CV | Market Commentary: GM launches $1 billion new deal; LifePoint trades up as many swap into new paper from older issue
|
5/23/2007 | BKCVHY | S&P rates LifePoint convertibles B
|
5/22/2007 | BKCVHY | Moody's lifts LifePoint loans to Ba2
|
5/22/2007 | BKCVHY | Fitch rates LifePoint convertibles B
|
5/22/2007 | BKCVHY | Fitch rates LifePoint convertibles B
|
5/22/2007 | CV | LifePoint prices $500 million seven-year convertibles at 3.5%, up 36.5%
|
5/22/2007 | CV | Market Commentary: Spansion, Intel rise on flash memory consolidation deal; LifePoint gains in gray despite aggressive talk
|
5/21/2007 | CV | LifePoint talks $500 million seven-year convertibles at 3.25%-3.75%, up 32.5%-37.5% for Tuesday
|
5/21/2007 | CV | Market Commentary: Cytyc surges on buyout; International Game falls on report, buyout uncertainty; LifePoint launches deal
|
4/27/2007 | BKCVHY | Fitch affirms LifePoint
|
1/17/2007 | BKCVHY | S&P downgrades LifePoint
|
7/5/2006 | BKCVHY | S&P affirms LifePoint Hospitals
|
7/3/2006 | BKCVHY | Moody's gives LifePoint Hospitals loan Ba3
|
5/2/2006 | BKCVHY | Fitch rates LifePoint loans BB-, convertibles B
|
1/10/2006 | CV | Market Commentary: LifePoint Hospitals, MGI Pharma convertibles weaker on lower guidance; Cephalon jumps; GM mixed
|
8/9/2005 | BKCVHY | Moody's affirms LifePoint Hospitals
|
8/9/2005 | BKCVHY | S&P affirms LifePoint Hospitals
|
8/5/2005 | CV | Market Commentary: LifePoint closes higher; Human Genome also gains, but automaker, REIT convertibles track lower
|
8/4/2005 | BKCVHY | S&P affirms LifePoint
|
8/4/2005 | BKCVHY | Moody's rates LifePoint notes B2
|
8/4/2005 | CV | New Issue: LifePoint sells $200 million 20-year convertibles to yield 3.25%, up 35%
|
8/4/2005 | CV | Market Commentary: Affordable Residential issue rises; Human Genome loses ground; LifePoint prices after the close
|
7/15/2005 | BKCVHY | S&P: LifePoint on watch
|
6/21/2005 | BKCVHY | S&P affirms LifePoint Hospitals
|
6/21/2005 | BKCVHY | Moody's affirms LifePoint Hospitals
|
6/15/2005 | CV | LifePoint investors convert $35.874 million notes to 757,482 shares
|
5/16/2005 | CV | LifePoint calls 41/2% convertibles
|
4/15/2005 | CV | LifePoint buys $172 million of Province's 41/4% convertibles
|
4/6/2005 | BKCVHY | Moody's affirms LifePoint
|
4/1/2005 | CV | LifePoint increases payment in tender for Province's 41/4% convertibles
|
3/29/2005 | CV | Market Commentary: LifePoint, Community Health rise; Schlumberger, Halliburton slide; Delta seesaws as deal buzz swirls
|
3/22/2005 | BKCVHY | Moody's rates LifePoint loan Ba3
|
3/22/2005 | BKCVHY | S&P rates LifePoint loan BB
|
3/18/2005 | CV | LifePoint tenders for Province's 41/4% convertibles
|
11/29/2004 | BKCVHY | S&P: LifePoint Hospitals still on watch
|
10/28/2004 | CV | Market Commentary: Option Care gains, Isolagen at bat; Health Management holders bail out; Bunge better; Avaya easier
|
8/20/2004 | BKCVHY | Moody's may cut LifePoint, Province
|
8/16/2004 | CV | Market Commentary: LifePoint, Province up on merger, lift takeover risk; American Tower deal seen repriced; Aquila emerges
|
8/16/2004 | BKCVHY | S&P: LifePoint on watch
|
5/27/2004 | BKCVHY | S&P: LifePoint unaffected
|
4/14/2004 | CV | Market Commentary: Walter bid at 100.25 in gray; Manugistics up on IBM deal; insurers, healthcare issues dive
|
3/1/2004 | CV | Market Commentary: Sepracor news wakes a raging bidding war in converts; 4 new deals emerge, including Amdocs
|
12/2/2003 | BKCVHY | S&P raises LifePoint facility to BB+
|
5/21/2003 | CV | Moody's rates AmerUs mandatory Baa3
|
4/30/2003 | BKCVHY | S&P says LifePoint unchanged
|
3/28/2003 | CV | Market Commentary: Continental, Alaska Air dive; Fleming feeds liquidity fears; warnings signal selling spree
|
7/22/2002 | CV | Market Commentary: Players remain on the sidelines as stocks continue sharp slide
|
6/25/2002 | CV | Moody's rates LifePoint convertible B3, raises outlook
|
6/19/2002 | CV | Market Commentary: Players sit out stock sell-off, dragging convertibles along
|
5/30/2002 | CV | Market Commentary: Adelphia, El Paso slip further on worries but market, new issues mostly higher
|
5/23/2002 | CV | LifePoint $50 million greenshoe exercised, raising convertibles to $250 million
|
5/17/2002 | CV | New Issue: LifePoint $200 million convertibles at 4.5% yield, up 30%
|
5/17/2002 | CV | Market Commentary: LifePoint gains in hungry market; El Paso drops on "bad" news
|
5/16/2002 | CV | Market Commentary: LifePoint prices drive-by deal in slow session
|
5/16/2002 | CV | LifePoint $200 million convertibles talked at 4.0-4.5% yield, up 27-32%
|